Neuropathology of Parkinson disease

Dickson, Dennis W.·2018·Parkinsonism & Related Disorders
DOI 10.1016/j.parkreldis.2017.07.033

Cited by (623)

Items 601–623 of 623

  1. ApoE in Synucleinopathies
    José Wagner Leonel Tavares-Júnior, Andre Borges Ferreira Gomes, Pedro Braga‐Neto · 2026 · Springer eBooks
  2. The mechanics of the movement
    Melissa A. Boswell · 2026 · Elsevier eBooks
  3. Microglia extracellular traps (MiETs) in Neurodegeneration: Mechanisms, Evidence Gaps, and Untapped Therapeutic Promise
    Lipika Sha, Sushmita Jha · 2026 · Advances in immunology
  4. α-synuclein pathology drives multi-scale reorganization of fronto-limbic networks and cognitive flexibility in the common marmoset
    Alessandro Zanini, Jesleen Saini, Jiayue Yang, Audrey Dureux, Maëva Gacoin, Constance Dollet, Kevin Johnston, Wen Luo, Irina Shlaifer, Thomas M. Durcan et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Advances in diffusion MRI in Parkinson's disease
    Jon Rodríguez-Antigüedad, Ignacio Aracil‐Bolaños, Javier Pagonabarraga, Jaime Kulisevsky, Frederic Sampedro · 2026 · Elsevier eBooks
  6. Unveiling the Role of Glutamate and NMDA Receptors in Alzheimer’s Disease
    Dipanjan Karati, Shreyasi Meur, Poulomi Sen, Swarupananda Mukherjee, Priya Ghosh · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
  7. Disease‐Duration–Specific Percentiles for Prospective Subtyping of Parkinson's Disease: A PPMI ‐Based Study
    Ahmed Negida, Nitai D. Mukhopadhyay, Brian D. Berman, Seyed‐Mohammad Fereshtehnejad, Matthew J. Barrett · 2026 · Movement Disorders Clinical Practice
  8. KLF4 in Parkinson’s Disease: Decoding the Molecular Puzzle of Neuroinflammation, Oxidative Stress, and Emerging Therapies
    Anjali Kumari, Khadga Raj Aran · 2026 · Current Medical Science
  9. Advancing early Parkinson's detection: A hybrid ensemble model with SHAP and LIME interpretability
    Hasibul Islam Shuvo, Gulam Rabbi, Md Assaduzzaman, Eram Mahamud, Nafiz Fahad, Tze Hui Liew, Ohidujjaman · 2026 · Informatics in Medicine Unlocked
  10. Plastamination in Human Brain: The Possible Role of Microplastics in Neuroinflammation and Parkinson’s Disease
    Ezia Guatteo, Maria Zelinda Romano, Nicola Berretta, Mario Ruggiero, Antonietta Santoro, Filomena Mazzeo, Rosaria Meccariello · 2026 · Microplastics
  11. Treating neurological diseases through epigenetic inhibition: A neuroepigenetic therapy hypothesis
    Doodipala Samba Reddy, Lauren Franklin, Victoria M. Golub, Hetvi Desai, Sreevidhya Ramakrishnan · 2026 · Journal of Pharmacology and Experimental Therapeutics
  12. Nanotechnology-enabled delivery of bioactive compounds for neuroprotection in Parkinson’s disease: mechanisms and future directions
    Praveen Kumar Gaur, Prachee Raje Bisht, Sonia Lal Gupta · 2026 · Journal of Biomaterials Science Polymer Edition
  13. Intrathecal Therapies for Neurodegenerative Diseases
    Manuel Menéndez‐González · 2026 · Neuromethods
  14. Transcranial direct current stimulation for learning and memory in Parkinson’s disease: a systematic review
    Carlos Caudet-Pastor, Daniel López-Malo, Aina Luque-García · 2026 · Frontiers in Neuroscience
  15. Co- and multipathologies need serious consideration for understanding Parkinson's disease pathogenesis and designing novel experimental therapeutic strategies
    Ashley V. Boehringer, Lorraine V. Kalia, Bastiaan R. Bloem, Jeffrey H. Kordower · 2026 · Journal of Parkinson s Disease
  16. From Design to Bedside: Brain-Targeted Engineered Nanoparticles and Predictive Modeling for Neurodegenerative Diseases Therapeutics
    Nguyen Nguyen, Muzhaozi Yuan, Ya Wang · 2026 · Pharmaceutical Research
  17. Zebrafish models provide insight into the biological classification of Parkinson's disease
    Wael Mohamed, Tiago F. Outeiro · 2026 · Elsevier eBooks
  18. TDP-43 and ALS - what's wrong with my membranes?
    Regina Dahlhaus, Israfil Yalcin, Julia Tischer, Ralf J. Braun · 2026 · Neurobiology of Disease
  19. Epigenetic processes in Parkinson disease
    Andrea Stoccoro, Martina Lari, Fabio Coppedè · 2026 · Handbook of clinical neurology
  20. Effects of Cyperus Esculentus Infused Diet on the Hippocampus in Rotenone-Induced Parkinson-like Disease Model in adult male Wistar Rats; a preliminary study
    Moyosoluwa Mary Dada, Stephen Taiye Adelodun, OLUWABUKUNMI ENIOLA AWOLUSI · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Macular Retinal Layer Thickness in Mild-to-Moderate Parkinson’s Disease
    Michael Y. Zhu, Sejal D. Patel, Nikki Daniels, John Hsu, Rachel D’Cunha, Alex Choi, Alice Haystead, Stephanie J. Chiu, Burton L. Scott, Dilraj Singh Grewal et al. · 2026 · Diagnostics
  22. Photobiomodulation in Parkinson’s disease: From pathogenesis to intervention
    Jie Shao, Qianting Deng, Luodan Yang · 2026 · Experimental Neurology
  23. Estimation of the prevalence of neuronal synuclein disease in the United States
    Patrik Brundin, Tanya Simuni, Un Jung Kang, Milton Biagioni, KENNETH L. MAREK, Gennaro Pagano · 2024 · Zenodo (CERN European Organization for Nuclear Research)